Moffitt mathematical model predicts patient outcomes to adaptive therapy

(H. Lee Moffitt Cancer Center & Research Institute) In an article published in Nature Communications, Moffitt Cancer Center researchers provide a closer look at a mathematical model and data showing that individual patient alterations in the prostate-specific antigen (PSA) biomarker early in cancer treatment can predict outcomes to later treatment cycles of adaptive therapy.